<DOC>
	<DOCNO>NCT02979249</DOCNO>
	<brief_summary>In medical literature conflict report whether iron improves symptoms patient EPP XLP . Giving iron people iron deficient think improve EPP symptom . However , never systematically test . Therefore , purpose study determine effect oral iron EPP XLP patient .</brief_summary>
	<brief_title>Oral Iron Erythropoietic Protoporphyrias</brief_title>
	<detailed_description>This clinical trial , mean purpose study intervention treatment . In study patient EPP XLP give standard dose iron pill monitor one year . There currently effective Food Drug Administration ( FDA ) approve treatment EPP XLP US . Giving iron patient low ferritin ( measure body iron store ) level may help improve EPP symptom decrease erythrocyte protoporphyrin level . Patients ask come study site every three month course year total five visit . At visit study doctor check participant blood urine sample take . Participants charge lab test do part study alone . In study visit phone call check see participant . All patient study receive iron pill cost .</detailed_description>
	<mesh_term>Protoporphyria , Erythropoietic</mesh_term>
	<mesh_term>Iron</mesh_term>
	<criteria>Enrollment Longitudinal Study Porphyrias Male female age ≥18 year History nonblistering cutaneous photosensitivity Biochemical find A marked increase erythrocyte protoporphyrin ( total erythrocyte protoporphyrin &gt; 400 ug/dL ) predominance metalfree protoporphyrin Serum ferritin ≤30 ng/mL baseline Able tolerate oral iron History liver bone marrow transplant clinically significant liver dysfunction determine investigator Known suspect allergy oral iron base patient report Clinical evidence active ongoing GI bleeding Use clinical experimental therapy past 3 month Individuals elevation porphyrin plasma erythrocyte due disease ( i.e . secondary porphyrinemia ) liver bone marrow diseases Patients clinically significant comorbid condition , opinion investigator , preclude participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Interventional</keyword>
	<keyword>open-label</keyword>
	<keyword>EPP</keyword>
	<keyword>XLP</keyword>
	<keyword>porphyria</keyword>
</DOC>